Human medicines European public assessment report (EPAR): Rezurock, Belumosudil, Status: Opinion
Human medicines European public assessment report (EPAR): Wayrilz, rilzabrutinib, Status: Opinion
Summary of opinion: Libtayo, 16/10/2025 Positive
Summary of opinion: Breyanzi, 16/10/2025 Positive
Summary of opinion: Scemblix, 16/10/2025 Positive
Summary of opinion: Gazyvaro, 16/10/2025 Positive
Summary of opinion: Cejemly, 16/10/2025 Positive
Summary of opinion: Pyrukynd, 16/10/2025 Positive
EMA confirms suspension of sickle cell disease medicine Oxbryta
Human medicines European public assessment report (EPAR): Austedo, deutetrabenazine, Status: Opinion